Bris­tol My­ers joins the le­gal fight over in­com­ing Medicare drug price ne­go­ti­a­tions

Bris­tol My­ers Squibb late last week joined Mer­ck and the US Cham­ber of Com­merce in chal­leng­ing the Biden ad­min­is­tra­tion’s sig­na­ture drug pric­ing re­form — al­low­ing, for the first time ever, Medicare to ne­go­ti­ate and rein in drug prices.

In its suit, filed in a New Jer­sey dis­trict court, BMS’ lawyers from Jones Day (the same firm hired by Mer­ck) joined Mer­ck in tak­ing is­sue with the In­fla­tion Re­duc­tion Act’s al­leged vi­o­la­tions of the First and Fifth Amend­ments, writ­ing:

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.